An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
18
01
2022
accepted:
06
12
2022
revised:
14
02
2023
pubmed:
3
2
2023
medline:
17
2
2023
entrez:
2
2
2023
Statut:
epublish
Résumé
The obligate intracellular Chlamydiaceae do not need to resist osmotic challenges and thus lost their cell wall in the course of evolution. Nevertheless, these pathogens maintain a rudimentary peptidoglycan machinery for cell division. They build a transient peptidoglycan ring, which is remodeled during the process of cell division and degraded afterwards. Uncontrolled degradation of peptidoglycan poses risks to the chlamydial cell, as essential building blocks might get lost or trigger host immune response upon release into the host cell. Here, we provide evidence that a primordial enzyme class prevents energy intensive de novo synthesis and uncontrolled release of immunogenic peptidoglycan subunits in Chlamydia trachomatis. Our data indicate that the homolog of a Bacillus NlpC/P60 protein is widely conserved among Chlamydiales. We show that the enzyme is tailored to hydrolyze peptidoglycan-derived peptides, does not interfere with peptidoglycan precursor biosynthesis, and is targeted by cysteine protease inhibitors in vitro and in cell culture. The peptidase plays a key role in the underexplored process of chlamydial peptidoglycan recycling. Our study suggests that chlamydiae orchestrate a closed-loop system of peptidoglycan ring biosynthesis, remodeling, and recycling to support cell division and maintain long-term residence inside the host. Operating at the intersection of energy recovery, cell division and immune evasion, the peptidoglycan recycling NlpC/P60 peptidase could be a promising target for the development of drugs that combine features of classical antibiotics and anti-virulence drugs.
Identifiants
pubmed: 36730465
doi: 10.1371/journal.ppat.1011047
pii: PPATHOGENS-D-22-00105
pmc: PMC9928106
doi:
Substances chimiques
Peptidoglycan
0
Bacterial Proteins
0
Peptide Hydrolases
EC 3.4.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1011047Subventions
Organisme : NIGMS NIH HHS
ID : R35 GM124798
Pays : United States
Informations de copyright
Copyright: © 2023 Reuter et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Curr Biol. 2016 Nov 7;26(21):R1158-R1160
pubmed: 27825456
PLoS One. 2010 May 28;5(5):e10890
pubmed: 20531937
J Bacteriol. 2007 Jun;189(11):3987-95
pubmed: 17384195
J Bacteriol. 1998 Mar;180(5):1215-23
pubmed: 9495761
Mol Biol Evol. 2011 Dec;28(12):3253-70
pubmed: 21690563
Infect Agents Dis. 1993 Apr;2(2):87-99
pubmed: 8162358
Mol Microbiol. 2012 Dec;86(5):1036-51
pubmed: 23062283
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Oct 1;66(Pt 10):1354-64
pubmed: 20944232
Curr Top Microbiol Immunol. 2018;412:1-33
pubmed: 27726004
PLoS One. 2015 Apr 07;10(4):e0122110
pubmed: 25849314
mBio. 2018 Dec 11;9(6):
pubmed: 30538181
Nat Commun. 2014 Apr 08;5:3578
pubmed: 24709914
J Bacteriol. 1985 Jul;163(1):305-10
pubmed: 3891732
J Pharmacobiodyn. 1986 Aug;9(8):672-7
pubmed: 3023601
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8478-83
pubmed: 12815105
Mol Syst Biol. 2006;2:2006.0008
pubmed: 16738554
J Bacteriol. 2003 Mar;185(6):1911-22
pubmed: 12618455
Science. 2003 Jun 6;300(5625):1584-7
pubmed: 12791997
Nature. 2014 Feb 27;506(7489):507-10
pubmed: 24336210
Nat Microbiol. 2020 Nov;5(11):1390-1402
pubmed: 32747796
Mol Microbiol. 2017 Dec;106(6):847-860
pubmed: 28975672
Antimicrob Agents Chemother. 2010 Dec;54(12):5379-80
pubmed: 20855744
Nat Commun. 2014 Jun 23;5:4200
pubmed: 24953095
Adv Appl Microbiol. 2020;112:67-103
pubmed: 32762868
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17909-14
pubmed: 17093042
mBio. 2018 Apr 3;9(2):
pubmed: 29615498
J Biol Chem. 2008 Jan 11;283(2):824-32
pubmed: 18003611
FEMS Microbiol Rev. 2015 Mar;39(2):262-75
pubmed: 25670734
Mol Microbiol. 2018 Jan;107(2):142-163
pubmed: 29178391
Trends Microbiol. 2006 Feb;14(2):70-7
pubmed: 16413190
Infect Immun. 2020 Apr 20;88(5):
pubmed: 32094256
Microbes Infect. 2011 Dec;13(14-15):1232-41
pubmed: 21816232
J Bacteriol. 1996 Sep;178(18):5347-52
pubmed: 8808921
PLoS Pathog. 2016 Aug 09;12(8):e1005822
pubmed: 27505160
PLoS One. 2011;6(10):e25129
pubmed: 22022378
mBio. 2021 Aug 31;12(4):e0134221
pubmed: 34311584
J Antibiot (Tokyo). 2017 Apr;70(4):366-377
pubmed: 27899793
PLoS Pathog. 2016 May 04;12(5):e1005590
pubmed: 27144308
Front Cell Infect Microbiol. 2014 Feb 26;4:19
pubmed: 24616885
Ann N Y Acad Sci. 2013 Jan;1277:54-75
pubmed: 23163477
J Bacteriol. 2020 Aug 10;202(17):
pubmed: 32540934
Biochemistry. 2001 Dec 25;40(51):15707-15
pubmed: 11747447
Biopolymers. 1999;51(1):99-107
pubmed: 10380357
Microbiol Mol Biol Rev. 2008 Jun;72(2):211-27, table of contents
pubmed: 18535144
FEMS Microbiol Lett. 1993 May 15;109(2-3):329-33
pubmed: 8339923
Chem Biol. 2015 Sep 17;22(9):1217-27
pubmed: 26364930
PLoS One. 2009 Nov 06;4(11):e7723
pubmed: 19893744
Microb Physiol. 2021;31(2):178-194
pubmed: 33794535
Pathog Dis. 2017 Jan 1;75(1):
pubmed: 28087650
Mol Microbiol. 2012 Jul;85(1):164-78
pubmed: 22624979
Nat Rev Microbiol. 2011 Dec 28;10(2):123-36
pubmed: 22203377
Nat Commun. 2013;4:2856
pubmed: 24292151
Front Microbiol. 2021 Dec 09;12:733850
pubmed: 34956109
mBio. 2015 Sep 15;6(5):e02327-14
pubmed: 26374125
Infect Immun. 2021 Jun 16;89(7):e0010821
pubmed: 33875479
Nature. 2016 Sep 29;537(7622):634-638
pubmed: 27525505
Mol Microbiol. 2015 Feb;95(3):365-82
pubmed: 25382739
Microb Drug Resist. 1996 Spring;2(1):63-72
pubmed: 9158724
mBio. 2019 Jul 16;10(4):
pubmed: 31311880
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Nat Commun. 2014 Jun 23;5:4201
pubmed: 24953137